Luke Halpern

Comprising most cases of this rare form of lymphoma, it is essential that pharmacists and treatment providers are aware of the health-related burdens patients with these subtypes consistently face.

Pharmacists will likely be the first contact for many affected patients, and they should be able to provide evidence-based advice on how to manage their infection.

Despite suggestions to the contrary in previously conducted small clinical trials, montelukast did not provide benefit in patients with COVID-19 symptoms.

The approval marks the first and only abuse-deterrent immediate release oxycodone formulation.

Though auto-injectors are still considered an appropriate first-line treatment for anaphylaxis, limited evidence exists surrounding their effectiveness in preventing fatal anaphylaxis.

Results indicate that sublingual epinephrine can resolve symptoms, including swelling of the face and throat, associated with oral allergy syndrome in minutes.

The risk of developing lymphoma remained nearly the same between patients with Crohn disease and ulcerative colitis.

Patients with hereditary angioedema who received sebetralstat earlier had faster complete resolution of their attacks.

Intravenous immunoglobulin prescriptions deemed non-compliant according to French national guidelines were more common in younger patients.

Recently announced trial results demonstrate the efficacy of the biologic in multiple disease indications.